Literature DB >> 26026129

Frequent High Expression of Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1) in Gastric Cancer.

Akiko Shida1, Nobue Futawatari1, Takashi Fukuyama2, Yoshinobu Ichiki3, Yoshihito Takahashi4, Yatsushi Nishi4, Noritada Kobayashi5, Hitoshi Yamazaki6, Masahiko Watanabe7.   

Abstract

BACKGROUND: The tumor-associated antigen Kita-Kyushu lung cancer antigen-1 (KK-LC-1) has been reported as not being expressed in normal tissues, except for the testis, and in the setting of non-small cell lung cancer. The present study demonstrated that KK-LC-1 is expressed in gastric cancer.
MATERIALS AND METHODS: We analyzed the expression of KK-LC-1 and cancer/testis antigens (CTAs) in surgical specimens of 49 gastric carcinomas. The expression of KK-LC-1 and CTAs was assessed using reverse transcription-polymerase chain reaction.
RESULTS: KK-LC-1 expression was observed in gastric carcinomas. The number of lesions with expression of KK-LC-1, Melanoma antigen gene encoding-A1 (MAGE-A1), MAGE-A3 and New York Esophageal squamous cell carcinoma-1 (NY-ESO-1) was 40 (81.6%), 17 (34.7%), 22 (44.9%) and 8 (16.3%) out of the 49 specimens, respectively.
CONCLUSION: KK-LC-1 should be categorized as a CTA. The frequency of KK-LC-1 expression was higher than that of the other CTAs. KK-LC-1 might be a useful target for immunotherapy and in diagnosis of gastric cancer. Copyright
© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  KK-LC-1; Kita-kyushu lung cancer antigen-1; cancer/testis antigen; gastric cancer

Mesh:

Substances:

Year:  2015        PMID: 26026129

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  14 in total

1.  Natural high-avidity T-cell receptor efficiently mediates regression of cancer/testis antigen 83 positive common solid cancers.

Authors:  Qingyang Li; Wei Hu; Baoyi Liao; Chanchan Song; Liangping Li
Journal:  J Immunother Cancer       Date:  2022-07       Impact factor: 12.469

2.  Correlation Between Expression of the Cancer/Testis Antigen KK-LC-1 and Helicobacter pylori Infection in Gastric Cancer.

Authors:  Takashi Fukuyama; Nobue Futawatari; Yoshinobu Ichiki; Akiko Shida; Taiga Yamazaki; Yatsushi Nishi; Hiroshi Nonoguchi; Yoshihito Takahashi; Hitoshi Yamazaki; Noritada Kobayashi
Journal:  In Vivo       Date:  2017 May-Jun       Impact factor: 2.155

3.  Multiomics analysis reveals CT83 is the most specific gene for triple negative breast cancer and its hypomethylation is oncogenic in breast cancer.

Authors:  Chen Chen; Dan Gao; Jinlong Huo; Rui Qu; Youming Guo; Xiaochi Hu; Libo Luo
Journal:  Sci Rep       Date:  2021-06-09       Impact factor: 4.379

4.  Early gastric cancer frequently has high expression of KK-LC-1, a cancer-testis antigen.

Authors:  Nobue Futawatari; Takashi Fukuyama; Rui Yamamura; Akiko Shida; Yoshihito Takahashi; Yatsushi Nishi; Yoshinobu Ichiki; Noritada Kobayashi; Hitoshi Yamazaki; Masahiko Watanabe
Journal:  World J Gastroenterol       Date:  2017-12-14       Impact factor: 5.742

5.  Expression of KK-LC-1, a cancer/testis antigen, at non-tumour sites of the stomach carrying a tumour.

Authors:  Takashi Fukuyama; Nobue Futawatari; Rui Yamamura; Taiga Yamazaki; Yoshinobu Ichiki; Akira Ema; Hideki Ushiku; Yatsushi Nishi; Yoshihito Takahashi; Toshikazu Otsuka; Hitoshi Yamazaki; Wasaburo Koizumi; Kosei Yasumoto; Noritada Kobayashi
Journal:  Sci Rep       Date:  2018-04-17       Impact factor: 4.379

6.  Targeted photodynamic therapy of cancer using a novel gallium (III) tris (ethoxycarbonyl) corrole conjugated-mAb directed against cancer/testis antigens 83.

Authors:  Ziyu Ye; Yanfang Liang; Yan Ma; Bihua Lin; Longbin Cao; Bin Wang; Zhao Zhang; Haibo Yu; Jixia Li; Mingyuan Huang; Keyuan Zhou; Qunzhou Zhang; Xinguang Liu; Jincheng Zeng
Journal:  Cancer Med       Date:  2018-06-01       Impact factor: 4.452

7.  Hypomethylation-mediated activation of cancer/testis antigen KK-LC-1 facilitates hepatocellular carcinoma progression through activating the Notch1/Hes1 signalling.

Authors:  Zhiqiang Chen; Xueliang Zuo; Liyong Pu; Yao Zhang; Guoyong Han; Long Zhang; Zhengshan Wu; Wei You; Jianjie Qin; Xinzheng Dai; Hongbing Shen; Xuehao Wang; Jindao Wu
Journal:  Cell Prolif       Date:  2019-03-20       Impact factor: 6.831

8.  Cancer targeting by TCR gene-engineered T cells directed against Kita-Kyushu Lung Cancer Antigen-1.

Authors:  Bridget Marcinkowski; Sanja Stevanović; Sarah R Helman; Scott M Norberg; Carylinda Serna; Benjamin Jin; Nikolaos Gkitsas; Tejas Kadakia; Andrew Warner; Jeremy L Davis; Lisa Rooper; Christian S Hinrichs
Journal:  J Immunother Cancer       Date:  2019-08-28       Impact factor: 13.751

Review 9.  CAR T-Cell Cancer Therapy Targeting Surface Cancer/Testis Antigens.

Authors:  Mie K Jakobsen; Morten F Gjerstorff
Journal:  Front Immunol       Date:  2020-09-02       Impact factor: 7.561

10.  Cancer/testis antigen, Kita-Kyushu lung cancer antigen-1 and ABCD stratification for diagnosing gastric cancers.

Authors:  Akiko Shida; Takashi Fukuyama; Nobue Futawatari; Haruki Ohmiya; Yoshinobu Ichiki; Tetsuro Yamashita; Yatsushi Nishi; Noritada Kobayashi; Hitoshi Yamazaki; Masahiko Watanabe; Yoshihito Takahashi
Journal:  World J Gastroenterol       Date:  2020-01-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.